Webinar Presents Strategies for Mitigating Risk in Emerging MarketsIssue: December 22, 2016
| Categories: Regulatory Topics
![]() A survey conducted by the Economist Intelligence Unit (EIU) explored biopharma’s growth strategies and how companies plan to manage risk while expanding their drug pipeline and geographical footprint. To challenge biopharma companies to go beyond barriers when entering emerging markets, there is a need for a new approach to partnerships in this complex, ever-changing environment. In early October, we presented a webinar, “Strategies for Mitigating Risk When Entering Emerging Markets,” in which we take a look at the changing biopharma landscape as well as strategies for scaling your process and implementing local production facilities in emerging markets. We also explored a flexible partnership model that accelerates speed-to-market and gives you complete control of your process and molecule, helping you to reduce cost and mitigate risk. Click here for more information. In This Same Issue |
Recent Articles
Article Search
Article Archives
Events
Webinars
|